ScholarIQanswers from OpenAlex & ORCID
Robert Spiera
ResearcherPublications, citations & collaboration network
Robert Spiera is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Robert Spiera have?
ScholarIQindexed works
Robert Spiera has 302 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Robert Spiera have?
ScholarIQcitation count
Robert Spiera has 17,226 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Robert Spiera?
ScholarIQh-index
Robert Spiera has an h-index of 62 in OpenAlex.
What is the i10-index of Robert Spiera?
ScholarIQi10-index
Robert Spiera has an i10-index of 148 in OpenAlex.
What is the ORCID of Robert Spiera?
ScholarIQorcid
The ORCID for Robert Spiera is on the source record.
What is the OpenAlex record for Robert Spiera?
ScholarIQopenalex
The OpenAlex for Robert Spiera is on the source record.
What are the most-cited papers on Robert Spiera?
ScholarIQmost cited works
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
John H. Stone, Peter A. Merkel, Robert Spiera, Philip Seo, Carol A. Langford, Gary S. Hoffman, Cees G. M. Kallenberg, E. William St. Clair, Anthony Turkiewicz, Nadia K. Tchao, Lisa Webber, Linna Ding, Lourdes P. Sejismundo, Kathleen Mieras, David Weitzenkamp, David Iklé, Vicki Seyfert‐Margolis, Mark Mueller, Paul Brunetta, Nancy B. Allen, Fernando C. Fervenza, Duvuru Geetha, Karina A. Keogh, Eugene Y. Kissin, Paul A. Monach, Tobias Peikert, Coen A. Stegeman, Steven R. Ytterberg, Ulrich Specks
Trial of Tocilizumab in Giant-Cell Arteritis
John H. Stone, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Martin Aringer, Daniël Blockmans, Elisabeth Brouwer, María C. Cid, Bhaskar Dasgupta, Jürgen Rech, Carlo Salvarani, Georg Schett, Hendrik Schulze‐Koops, Robert Spiera, Sebastian Unizony, Neil Collinson
Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
Ulrich Specks, Peter A. Merkel, Philip Seo, Robert Spiera, Carol A. Langford, Gary S. Hoffman, Cees G. M. Kallenberg, E. William St. Clair, Barri J. Fessler, Linna Ding, Lisa Viviano, Nadia K. Tchao, Deborah Phippard, Adam L. Asare, Noha Lim, David Iklé, Brett Jepson, Paul Brunetta, Nancy B. Allen, Fernando C. Fervenza, Duvuru Geetha, Karina A. Keogh, Eugene Y. Kissin, Paul A. Monach, Tobias Peikert, Coen A. Stegeman, Steven R. Ytterberg, Mark Mueller, Lourdes P. Sejismundo, Kathleen Mieras, John H. Stone
A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score
John H. Stone, Gary S. Hoffman, Peter A. Merkel, Yuan‐I Min, Misty L. Uhlfelder, David B. Hellmann, Ulrich Specks, Nancy B. Allen, John C. Davis, Robert Spiera, Leonard H. Calabrese, Fredrick M. Wigley, N Maiden, R. Valente, John L. Niles, Kenneth H. Fye, Joseph W. McCune, E. William St. Clair, Raashid Luqmani, for the International Network for the Study of the Systemic Vasculitides (INSSYS)
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Lisa Rice, Cristina M. Padilla, Sarah McLaughlin, Allison L. Mathes, Jessica Ziemek, Salma Goummih, Sashidhar Nakerakanti, Michael York, Giuseppina Farina, Michael L. Whitfield, Robert Spiera, Romy Christmann, Jessica Gordon, Janice Weinberg, Robert W. Simms, Robert Lafyatis